SCHEMBL4354237

SCHEMBL4354237

COc1cc(C(F)(F)F)ccc1C(=O)c1cnc(SC)nc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.41
CDK1 P06493 3/20 0.41
CDK4 P11802 2/20 0.41
CCND1 P24385 2/20 0.41
CDK2 P24941 2/20 0.41
PDE4B Q07343 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RORB Q92753 3/20 0.40
AVPR2 P30518 1/20 0.38
GPR27 Q9NS67 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13621486 0.89 SMN1; SMN2 (0.44) CFTRCDK1CDK4CCND1CDK2
SCHEMBL4352682 0.81 CDK1 (0.40) CFTRCDK1CDK4CCND1CDK2
SCHEMBL4361083 0.79 CDK1 (0.53) CDK1CDK4CCND1CDK2PDE4B
SCHEMBL4355841 0.79 CDK1 (0.38) CFTRCDK1CDK4CCND1CDK2
SCHEMBL13621473 0.74 CDK1 (0.51) CDK1CDK4CCND1CDK2MEN1
SCHEMBL4350556 0.73 CDK1 (0.54) CDK1CDK4CCND1CDK2PDE4B
SCHEMBL4355439 0.73 CDK1 (0.48) CDK1CDK4CCND1CDK2AVPR2
SCHEMBL4350466 0.72 CDK1 (0.44) CDK1CDK4CCND1CDK2PDE4B
SCHEMBL4355441 0.72 CDK1 (0.80) CDK1CDK4CCND1CDK2
SCHEMBL4354299 0.70 MAPK1 (0.45) CDK1CDK4CCND1CDK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US claimed
US-20060229330-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID J 2006-10-12 US claimed
US-20040162303-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID JOSEPH (US) 2004-08-19 US claimed
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7157455-B2 4-Aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-02 US disclosed
US-20060229330-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID J 2006-10-12 US disclosed
EP-1628619-A2 4-AMINOPYRIMIDINE-5-ONE F.HOFFMANN-LA ROCHE AG (CH) 2006-03-01 EP disclosed
US-20040162303-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID JOSEPH (US) 2004-08-19 US disclosed
WO-2004069139-A2 4-AMINOPYRIMIDIN-5-YL-METHANONE DERIVATIVES FOR INHIBITION OF CDK4 ACTIVITY F.HOFFMANN-LA ROCHE AG (CH) 2004-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162303-A1 4-aminopyrimidine-5-one derivatives CDK4, CDKL4, CDK6 CFTR 4577/4885CDK1 6/4885CDK4 1/4885
US-20060229330-A1 4-aminopyrimidine-5-one derivatives CDK4, CDKL4, CDK2 CFTR 4859/4885CDK1 6/4885CDK4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.